Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonistMarc P Maillard, Christine Perregaux, Catherine Centeno, et al.Kidney International|September 13, 2003
Renal hemodynamic and tubular responses to salt in women using oral contraceptivesAntoinette Pechère-Bertschi, Marc Maillard, Hans Stalder, et al.Journal of Hypertension|August 18, 2004
Renal endothelin receptor type B upregulation in rats with low or high renin hypertensionNoureddine Brakch, Saad Abdel-Sayed, Flore Allemandou, et al.Regulatory Peptides|March 1, 2003
Angiotensin II mediates catecholamine and neuropeptide Y secretion in human adrenal chromaffin cells through the AT1 receptorClaudia Cavadas, Daniela Grand, François Mosimann, et al.Biology of the Cell|April 27, 2005
Neuropeptide Y expression, localization and cellular transducing effects in HUVECAntonio P Silva, Jocelyne E Kaufmann, Cécile Vivancos, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 30, 2002
The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functionsFrançois P Pralong, Christine Gonzales, Marie-Jeanne Voirol, et al.Hypertension (Dallas, Tex. : 1979)|August 11, 2004
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- miceLucia Mazzolai, Michel A Duchosal, Martine Korber, et al.Journal of Hypertension|September 27, 2012
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapyMichael A Weber, Stevo Julius, Sverre E Kjeldsen, et al.Lancet (London, England)|June 23, 2004
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialStevo Julius, Sverre E Kjeldsen, Michael Weber, et al.Lancet (London, England)|June 23, 2004
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE TrialMichael A Weber, Stevo Julius, Sverre E Kjeldsen, et al.Pageof 5